Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Elson

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Investigational New Drugs|May 1, 1990
Evaluation of carboplatin (NSC 241240) in patients with recurrent or metastatic renal cell carcinomaD L Trump, P Elson
Cancer Treatment Reports|February 1, 1982
Phase II evaluation of VM-26 in patients with metastatic transitional cell carcinoma of the urinary tract: an Eastern Cooperative Oncology Group studyR Qazi, P Elson, J D Khandekar
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Importance of continued testicular suppression in hormone-refractory prostate cancerC D Taylor, P Elson, D L Trump
Cancer|July 1, 1984
Treatment of metastatic prostate cancer. An analysis of response criteria in patients with measurable soft tissue diseaseD L Citrin, P Elson, W D DeWys
Journal of the South Carolina Medical Association (1975)|August 1, 1979
Does MCAT predict clinical performance?D L Shaw, P M Randels, P Elson
The American Journal of Medicine|May 1, 1984
Decreased serum phosphate levels after high-dose estrogens in metastatic prostate cancer. Possible implicationsD L Citrin, P Elson, M S Kies, et al.
Cancer|June 15, 1982
Combination chemotherapy for advanced endometrial cancer. An evaluation of three regimensJ Horton, P Elson, P Gordon, et al.
Cancer Treatment Reports|October 1, 1987
Carboplatin in advanced, refractory germ cell neoplasms: a phase II Eastern Cooperative Oncology Group StudyD L Trump, P Elson, H Brodovsky, et al.
International Journal of Radiation Oncology, Biology, Physics|August 1, 1986
Phase II trial of misonidazole (MISO) and cyclophosphamide (CYC) in metastatic renal cell carcinomaD Glover, D Trump, L Kvols, et al.
Cancer|February 1, 1994
An Eastern Cooperative Oncology Group phase II trial of trimetrexate in the treatment of advanced urothelial carcinomaR S Witte, P Elson, J Khandakar, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Investigational New Drugs|May 1, 1990
Evaluation of carboplatin (NSC 241240) in patients with recurrent or metastatic renal cell carcinomaD L Trump, P Elson
Cancer Treatment Reports|February 1, 1982
Phase II evaluation of VM-26 in patients with metastatic transitional cell carcinoma of the urinary tract: an Eastern Cooperative Oncology Group studyR Qazi, P Elson, J D Khandekar
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Importance of continued testicular suppression in hormone-refractory prostate cancerC D Taylor, P Elson, D L Trump
Cancer|July 1, 1984
Treatment of metastatic prostate cancer. An analysis of response criteria in patients with measurable soft tissue diseaseD L Citrin, P Elson, W D DeWys
Journal of the South Carolina Medical Association (1975)|August 1, 1979
Does MCAT predict clinical performance?D L Shaw, P M Randels, P Elson
The American Journal of Medicine|May 1, 1984
Decreased serum phosphate levels after high-dose estrogens in metastatic prostate cancer. Possible implicationsD L Citrin, P Elson, M S Kies, et al.
Cancer|June 15, 1982
Combination chemotherapy for advanced endometrial cancer. An evaluation of three regimensJ Horton, P Elson, P Gordon, et al.
Cancer Treatment Reports|October 1, 1987
Carboplatin in advanced, refractory germ cell neoplasms: a phase II Eastern Cooperative Oncology Group StudyD L Trump, P Elson, H Brodovsky, et al.
International Journal of Radiation Oncology, Biology, Physics|August 1, 1986
Phase II trial of misonidazole (MISO) and cyclophosphamide (CYC) in metastatic renal cell carcinomaD Glover, D Trump, L Kvols, et al.
Cancer|February 1, 1994
An Eastern Cooperative Oncology Group phase II trial of trimetrexate in the treatment of advanced urothelial carcinomaR S Witte, P Elson, J Khandakar, et al.
Pageof 6